Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,529 | 855 | 98.7% |
| Consulting Fee | $150.00 | 1 | 1.2% |
| Education | $18.53 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,092 | 183 | $0 (2024) |
| Lilly USA, LLC | $1,114 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $898.92 | 49 | $0 (2023) |
| PFIZER INC. | $837.37 | 76 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $803.94 | 63 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $640.68 | 36 | $0 (2024) |
| Amgen Inc. | $635.56 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $562.51 | 34 | $0 (2022) |
| ABBVIE INC. | $537.53 | 31 | $0 (2024) |
| GlaxoSmithKline, LLC. | $454.14 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,946 | 109 | Lilly USA, LLC ($287.40) |
| 2023 | $1,787 | 103 | Lilly USA, LLC ($381.81) |
| 2022 | $1,809 | 123 | Novo Nordisk Inc ($534.16) |
| 2021 | $1,707 | 113 | Novo Nordisk Inc ($377.31) |
| 2020 | $1,181 | 83 | Janssen Pharmaceuticals, Inc ($243.73) |
| 2019 | $1,175 | 87 | Janssen Pharmaceuticals, Inc ($242.21) |
| 2018 | $1,386 | 111 | PFIZER INC. ($225.24) |
| 2017 | $1,707 | 129 | PFIZER INC. ($314.93) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.78 | General |
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 11/16/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Biological | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.98 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 51 | 4,142 | 8,512 | $541,871 | $194,405 |
| 2022 | 50 | 3,950 | 8,191 | $524,722 | $190,199 |
| 2021 | 45 | 4,332 | 8,870 | $307,841 | $180,198 |
| 2020 | 55 | 5,742 | 12,171 | $414,709 | $226,526 |
All Medicare Procedures & Services
201 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 182 | 676 | $197,392 | $63,773 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 176 | 176 | $52,299 | $22,699 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 138 | 326 | $67,156 | $21,792 | 32.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 94 | 95 | $11,590 | $6,683 | 57.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 199 | 517 | $16,027 | $5,316 | 33.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 197 | 576 | $9,143 | $4,690 | 51.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 177 | 326 | $13,040 | $4,230 | 32.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 196 | 552 | $11,040 | $4,164 | 37.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 133 | 251 | $15,060 | $3,709 | 24.6% |
| 82746 | Folic acid level, serum | Office | 2023 | 134 | 251 | $7,530 | $3,632 | 48.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 99 | 100 | $5,000 | $3,094 | 61.9% |
| 83735 | Magnesium level | Office | 2023 | 176 | 469 | $14,070 | $3,057 | 21.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 84 | 99 | $5,940 | $2,787 | 46.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $7,939 | $2,780 | 35.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 30 | 48 | $7,056 | $2,631 | 37.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $6,952 | $2,439 | 35.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 104 | 180 | $5,040 | $2,405 | 47.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 97 | 141 | $7,050 | $2,311 | 32.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 212 | $6,784 | $2,301 | 33.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 198 | 548 | $9,864 | $2,271 | 23.0% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 45 | 55 | $4,565 | $2,225 | 48.7% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 99 | 175 | $4,550 | $2,188 | 48.1% |
| 84100 | Phosphate level | Office | 2023 | 177 | 469 | $4,221 | $2,163 | 51.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,524 | $2,002 | 44.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,736 | $1,570 | 57.4% |
About Dr. Thomas Selznick, D.O
Dr. Thomas Selznick, D.O is a Family Medicine healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679553465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Selznick, D.O has received a total of $12,698 in payments from pharmaceutical and medical device companies, with $1,946 received in 2024. These payments were reported across 858 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($12,529).
As a Medicare-enrolled provider, Selznick has provided services to 18,166 Medicare beneficiaries, totaling 37,744 services with total Medicare billing of $791,328. Data is available for 4 years (2020–2023), covering 201 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Livonia, MI
- Active Since 01/19/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679553465
Products in Payments
- Ozempic (Drug) $1,011
- XARELTO (Drug) $780.35
- Rybelsus (Drug) $578.72
- JARDIANCE (Drug) $577.78
- MOUNJARO (Drug) $513.64
- Kerendia (Drug) $374.12
- CHANTIX (Drug) $367.39
- VRAYLAR (Drug) $310.99
- ZENPEP (Drug) $269.59
- EMGALITY (Drug) $266.14
- TRELEGY ELLIPTA (Drug) $256.25
- JANUVIA (Drug) $255.32
- Otezla (Drug) $244.67
- FARXIGA (Drug) $236.02
- FREESTYLE LIBRE 2 (Device) $206.77
- Prolia (Biological) $191.05
- TOUJEO (Drug) $182.72
- EVENITY (Biological) $181.70
- PREVNAR - 13 (Biological) $181.66
- Victoza (Drug) $179.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Livonia
Martin Erickson, D.o, D.O
Family Medicine — Payments: $13,875
J.adam Kellman, D.o, D.O
Family Medicine — Payments: $13,031
Paul Jackson, D.o, D.O
Family Medicine — Payments: $12,900
William Penn, D.o, D.O
Family Medicine — Payments: $9,628
Dr. Keith Tobin, D.o, D.O
Family Medicine — Payments: $7,899
Dr. Michael Burry, D.o, D.O
Family Medicine — Payments: $7,706